Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 USD | +1.83% | -5.52% | +101.20% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 173M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -32M | EV / Sales 2024 * | - |
Net cash position 2024 * | 119K | Net Debt 2025 * | 50M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.81
x | P/E ratio 2025 * |
-9.05
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.63% |
Latest transcript on Rani Therapeutics Holdings, Inc.
1 day | +1.83% | ||
1 week | -5.52% | ||
Current month | +114.79% | ||
1 month | +110.06% | ||
3 months | +86.59% | ||
6 months | +235.68% | ||
Current year | +101.20% |
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 68 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 53 | 21-04-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.68 | +1.83% | 42,043 |
24-04-25 | 6.56 | -6.15% | 189,613 |
24-04-24 | 6.99 | +4.48% | 138,491 |
24-04-23 | 6.69 | +0.30% | 92,585 |
24-04-22 | 6.67 | -5.66% | 194,736 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.20% | 173M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- RANI Stock